Ularitide: Clinical Trials

4 trials of Ularitide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Withdrawn 1
Phase 31Completed 1

Follow Ularitide: new trials by email Literature Review of Ularitide trials Research Report on Ularitide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
Ularitide, Placebo - Cirrhosis, Liver, Ascites Hepatic
Phase 2TerminatedUniversity of Aarhus172020-08-012023-05-18
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
Ularitide, Placebo - Acute Decompensated Heart Failure
Phase 3CompletedCardiorentis21572012-07-012018-10-23
Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol
URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE), MANNITOL - Renal Dysfunction, Acute Renal Failure
Phase 2CompletedRocky Mountain Cancer Centers202003-07-012008-06-03
A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure
Ularitide - Heart Failure, Congestive
Phase 1WithdrawnFacet Biotech322009-07-20

Conditions studied

Acute Kidney Injury (1)  ·  Ascites (1)  ·  Fibrosis (1)  ·  Heart Failure (1)  ·  Liver Cirrhosis (1)  ·  Renal Insufficiency (1)

Sponsors

Cardiorentis (1)  ·  Facet Biotech (1)  ·  Rocky Mountain Cancer Centers (1)  ·  University of Aarhus (1)

Countries

United States (3)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Latvia (1)

Top investigators

Barry Greenberg, MD (1)  ·  Chirag R Parikh, MD, PhD (1)  ·  Christopher O'Connor, MD (1)  ·  Daniel Fuleihan, MD (1)  ·  Darshak Karia, MD (1)  ·  Elie Korban, MD (1)  ·  Gregory Ewald, MD (1)  ·  Milton Packer, MD (1)  ·  Nirav Y. Raval, MD (1)  ·  Richard Nowak, MD (1)  ·  William Cotts, MD (1)  ·  William F. Peacock, MD (1)

Results publications

PMID 27862700, PMID 28402745

NIH funding

2019 (1)